Clinical characteristics and treatment of patients with small cell prostate cancer: analysis of a real-world cohort from an oncology database.

ABSTRACT:

Background

Small cell prostate cancer (SCPC) is a rare, aggressive disease with limited clinical data to guide treatment. In this retrospective study, we evaluated clinical, treatment, and outcomes data for patients with SCPC.

Methods

Patients with SCPC were selected from CancerLinQ Discovery^®, a United States-based de-identified clinical database derived from the electronic health records of over 60 medical oncology organizations. A diagnosis of SCPC was made based on a tumor histology code of small cell carcinoma. The primary outcome of this study was assessing first-line systemic therapy within 1 year of diagnosis of SCPC.

Results

74 patients with SCPC who received systemic therapy between 2010-2023 were identified. The majority had documented metastatic

SUBMITTER: Eule CJ 

PROVIDER: S-EPMC12604463 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature